TIG Advisors’s Drugs Made In America Acquisition II Corp Unit DMIIU Stock Holding History
Bought
Maintained
Sold
Other funds holding DMIIU
TIG Advisors's DMIIU Position: Q2 2026 in Review
TIG Advisors sold out of Drugs Made In America Acquisition II Corp Unit (DMIIU) in Q2 2026, closing a stake of 500,000 shares — an estimated $5.02M sold.
TIG Advisors first reported a position in DMIIU in Q3 2025 and held it in 3 quarters. The position peaked at $5.02M in Q1 2026. 11 funds tracked by Wall St. Rank hold DMIIU as of Q2 2026.
- TIG Advisors reported no remaining Drugs Made In America Acquisition II Corp Unit position as of Q2 2026 after selling out during the quarter.
- TIG Advisors sold 500,000 Drugs Made In America Acquisition II Corp Unit shares in Q2 2026, an estimated $5.02M.
- TIG Advisors first reported a position in Drugs Made In America Acquisition II Corp Unit in Q3 2025 and held it in 3 quarters.
- TIG Advisors's Drugs Made In America Acquisition II Corp Unit position peaked at $5.02M in Q1 2026.
- 11 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Unit as of Q2 2026.
Based on TIG Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.